217 related articles for article (PubMed ID: 8818435)
21. White coat hypertension and haemostatic/fibrinolytic balance disorders.
Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
[TBL] [Abstract][Full Text] [Related]
22. [Anomalies of coagulation and fibrinolytic activity in patients with chronic pulmonary thromboembolism].
Aiello E; Presbitero P; Stella S; Borchiellini A; Garis G; Bazzan M; Schinco P; Tamponi G
G Ital Cardiol; 1993 Apr; 23(4):345-51. PubMed ID: 8319862
[TBL] [Abstract][Full Text] [Related]
23. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
24. Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders.
Opatrný K; Zemanová P; Mares J; Vít L; Opatrná S; Sefrna F; Hejda V; Tomsů M; Eiselt J; Massry SG
Am J Nephrol; 2002; 22(5-6):429-36. PubMed ID: 12381940
[TBL] [Abstract][Full Text] [Related]
25. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension.
Welsh CH; Hassell KL; Badesch DB; Kressin DC; Marlar RA
Chest; 1996 Sep; 110(3):710-7. PubMed ID: 8797416
[TBL] [Abstract][Full Text] [Related]
26. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
27. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.
Devin JK; Blevins LS; Verity DK; Chen Q; Bloodworth JR; Covington J; Vaughan DE
J Clin Endocrinol Metab; 2007 Sep; 92(9):3633-9. PubMed ID: 17579195
[TBL] [Abstract][Full Text] [Related]
28. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
Olman MA; Marsh JJ; Lang IM; Moser KM; Binder BR; Schleef RR
Circulation; 1992 Oct; 86(4):1241-8. PubMed ID: 1394930
[TBL] [Abstract][Full Text] [Related]
29. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
Stegnar M; Mavri A
Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
[TBL] [Abstract][Full Text] [Related]
30. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
32. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
[TBL] [Abstract][Full Text] [Related]
33. Impaired fibrinolysis and insulin resistance in patients with hypertension.
Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
[TBL] [Abstract][Full Text] [Related]
34. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
[TBL] [Abstract][Full Text] [Related]
35. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
36. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
37. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
38. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
39. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
[TBL] [Abstract][Full Text] [Related]
40. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
